How does EMA collaborate with other organizations on neonatal disorders?
The EMA collaborates with various national and international organizations to address neonatal disorders. These collaborations include working with the World Health Organization (WHO), the United States Food and Drug Administration (FDA), and other regulatory bodies. Such partnerships facilitate the sharing of information and harmonization of regulatory standards, ultimately improving the availability and safety of neonatal medicines globally.
